Angioinsight

Minnetonka, MN · Founded 2013 · Privately Held (backing)

Developer of artificial intelligence (AI) diagnostic tools designed to improve the detection and management of cardiovascular disease. Angioinsight is based in Minnetonka, MN and was founded in 2013. It is valued at about $18 million as of Oct 2026, set by institutional fund marks. It has raised $10.5 million.

PMV mark · valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$10.5M
Last round
—

Who backs Angioinsight?

6 investors
InvestorType
US National Science FoundationOther
Innovation PartnershipsVenture capital
Avestria Ventures—
Dakota Venture Group—
Joyce and Don Massey Family Foundation—
Michigan Institute for Data Science—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Angioinsight investors

6 investors are on record for Angioinsight, including US National Science Foundation, Innovation Partnerships, Avestria Ventures and Dakota Venture Group.

Free account
More of Angioinsight with a free account
  • ·Watch Angioinsight: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Angioinsight. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View